Melasma vs. Hyperpigmentation: A Doctor Explains the Key Differences

Feb 24
12 min read

All melasma is hyperpigmentation, but not all hyperpigmentation is melasma. This guide explains the key differences in causes and appearance, helping you identify your skin concern for proper treatment.

What Is Hyperpigmentation?

Hyperpigmentation is not a single diagnosis. It is a descriptive umbrella term covering any situation in which an area of skin appears noticeably darker than the surrounding skin, due to localised excess production of melanin — the brown pigment produced by specialised cells called melanocytes. This overproduction can be triggered by a wide range of factors, including UV radiation, skin inflammation, hormonal fluctuations, ageing, and certain medications.

Understanding which type of hyperpigmentation is present is the foundation of effective management. Applying treatments designed for one type to another can produce disappointing or even counterproductive results. The three most clinically relevant types are melasma, post-inflammatory hyperpigmentation, and solar lentigines.

Post-Inflammatory Hyperpigmentation (PIH)

PIH arises as a direct response to skin injury or inflammation. When the skin heals from a blemish, insect bite, eczema flare, or any form of dermal trauma, melanocytes can over-produce pigment during the repair process. The result is a flat, discoloured mark at the site of the original injury. The colour of PIH varies from pink or red in lighter skin tones to dark brown or near-black in individuals with more melanin-rich complexions (Fitzpatrick skin types IV to VI — tones that are common in Singapore's diverse population). PIH can appear anywhere on the body where inflammation has occurred.

Solar Lentigines (Sunspots / Age Spots)

Solar lentigines are flat, well-defined, oval-shaped brown patches that develop on skin that has been exposed to cumulative UV radiation over time. They are most common on the face, hands, shoulders, and upper back. Although more prevalent in adults over 50, they can appear earlier in individuals with significant cumulative sun exposure — a particularly relevant consideration in Singapore, where UV index levels are consistently high year-round.

What Is Melasma?

Melasma is a specific, chronic form of hyperpigmentation characterised by symmetrical brown or grey-brown patches on the face. Unlike PIH or sunspots — which tend to present as smaller or more isolated marks — melasma typically manifests as larger, softly bordered patches that create a mask-like appearance on the cheeks, forehead, bridge of the nose, and upper lip. This presentation historically gave rise to the term "mask of pregnancy" (also referred to as chloasma), although melasma is by no means exclusive to pregnancy.

The condition predominantly affects women and is especially prevalent among individuals with Fitzpatrick skin types III to VI — tones that are common across South, Southeast, and East Asian populations. This makes melasma a particularly significant dermatological concern in Singapore. Melasma is prone to recurrence and generally requires sustained management rather than a single course of treatment.

Key Triggers of Melasma

Melasma results from a complex interplay of factors. The most consistently identified contributors are hormonal influences and UV exposure.

Hormonal fluctuations: Oestrogen and progesterone are thought to sensitise melanocytes, making them hyperresponsive to light. This explains why melasma frequently presents or worsens during pregnancy, when taking oral contraceptive pills, or during hormone replacement therapy.
UV and light exposure: Ultraviolet radiation from the sun is the most significant environmental trigger for melasma. Some research also suggests that high-energy visible (HEV) light and heat may contribute to flare-ups in susceptible individuals, although this area of study is still developing and the evidence is not yet definitive.
Genetic predisposition: A family history of melasma increases an individual's likelihood of developing the condition.
Other contributing factors: Thyroid dysfunction, certain medications, and occasionally fragranced skincare products have been reported as potential aggravating factors in susceptible individuals.

Melasma vs. Hyperpigmentation: Three Key Differences

Although melasma is technically a form of hyperpigmentation, the practical differences between melasma and other common hyperpigmentation types are significant enough to influence every aspect of diagnosis and management. A doctor evaluating skin discolouration will typically assess three primary characteristics: appearance, cause, and location.

Difference 1 — Appearance and Pattern

The visual presentation of discolouration provides the most immediate diagnostic clue. Melasma is characterised by larger patches with soft, poorly defined borders — often described as blotchy or cloud-like — appearing in a near-symmetrical distribution across the face. Sunspots are typically smaller, more distinctly bordered, and randomly distributed on sun-exposed skin. PIH presents as isolated marks at the exact site of a prior blemish or injury, with borders that correspond directly to the area of inflammation.

Difference 2 — Causes and Triggers

The underlying driver of excess melanin production is the most important distinguishing factor. General hyperpigmentation types are primarily caused by direct UV damage (sunspots) or the skin's healing response to injury (PIH). Melasma has an additional hormonal dimension: the melanocytes in melasma-affected skin appear to be sensitised by oestrogen and progesterone, making them hyperresponsive to light and heat. This is why melasma can worsen even with relatively brief or minor sun exposure that would not trigger other forms of pigmentation.

Difference 3 — Location on the Face and Body

Melasma has a strong predilection for the face — specifically the cheeks, forehead, bridge of the nose, and upper lip — and almost always presents symmetrically. It occasionally appears on other sun-exposed areas such as the forearms or neck, but facial involvement is the hallmark. Sunspots are most common on the face, hands, chest, and shoulders. PIH can appear anywhere on the body where inflammation has previously occurred, making its distribution considerably more variable.

How a Doctor Diagnoses Skin Discolouration

Self-diagnosis based on photographs or online descriptions can be misleading — particularly given how differently these conditions present across different skin tones. An accurate clinical diagnosis is the essential first step before any treatment is initiated, since approaches that are effective for sunspots can sometimes exacerbate melasma.

A thorough consultation will begin with a detailed medical and lifestyle history. Your doctor will ask when the discolouration first appeared, whether there is any link to hormonal changes (such as pregnancy, oral contraceptive use, or hormone therapy), your level of sun exposure, and whether similar conditions run in your family. The pattern, colour, and location of the discolouration will be carefully assessed through visual examination.

Many skin doctors also use a Wood's lamp — a handheld UV light device used in a darkened room — to help determine the depth of pigmentation in the skin. Epidermal (superficial) pigment appears more enhanced under Wood's lamp examination, while dermal (deeper) pigment is less clearly delineated. This distinction directly informs which treatment approaches are likely to be most effective. Where the diagnosis is uncertain or a more serious skin condition needs to be excluded, a skin biopsy may be recommended.

Treatment Options for General Hyperpigmentation (PIH and Sunspots)

Once the type of hyperpigmentation has been confirmed, a treatment plan can be developed. For PIH and sunspots, management typically combines topical agents with professional in-clinic procedures, tailored to the severity and depth of discolouration.

Topical Ingredients

Topical treatments form the backbone of hyperpigmentation management. They work by inhibiting melanin synthesis, accelerating cell turnover, or reducing pigment transfer. Consistency of use over several weeks to months is essential to see meaningful improvement.

Retinoids (retinol and prescription tretinoin): Vitamin A derivatives that accelerate epidermal cell turnover, helping to shed pigmented surface cells. Prescription-strength formulations are available through a doctor.
Vitamin C (L-ascorbic acid): An antioxidant that inhibits tyrosinase — a key enzyme in the melanin production pathway — and may help brighten the complexion over time.
Niacinamide (Vitamin B3): Reduces the transfer of melanin from melanocytes to neighbouring keratinocytes; its anti-inflammatory properties may also benefit PIH.
Azelaic acid: Particularly useful for PIH secondary to acne; combines anti-inflammatory and melanin-suppressing properties.
Alpha-hydroxy acids (AHAs — glycolic acid, lactic acid): Chemical exfoliants that help accelerate the removal of superficially pigmented cells.
Kojic acid, arbutin, licorice root extract: Tyrosinase inhibitors commonly found in brightening formulations.

In-Clinic Procedures

For more persistent or deeper pigmentation, a doctor may recommend professional procedures. The choice of treatment should always be made following clinical assessment of the individual's skin type and the nature of the discolouration. All in-clinic procedures should be performed by a licensed medical professional.

Chemical peels: Application of a chemical solution to remove outer skin layers, promoting the emergence of more evenly pigmented skin. Peel depth (superficial to medium) depends on clinical need and skin type.
Laser and light-based treatments: Various energy-based devices can target melanin deposits. Intense Pulsed Light (IPL) is commonly considered for solar-induced hyperpigmentation such as sunspots. Q-switched Nd:YAG lasers deliver short, high-energy pulses that fragment pigment. The Vbeam pulsed dye laser, while primarily used for vascular concerns, may be considered by a doctor in specific contexts. Fractional lasers stimulate skin remodelling through controlled thermal zones. Suitability of any laser for a specific patient depends on skin type, pigment depth, and medical judgement.
Microneedling: Creates controlled micro-channels in the skin, stimulating healing and enhancing the penetration of topical brightening agents.

Specialised Management Strategies for Melasma

Melasma requires a fundamentally different approach from other hyperpigmentation types. Because the melanocytes in melasma-affected skin are in a sensitised, reactive state, treatments that generate heat, irritation, or inflammation carry a genuine risk of triggering further pigment production — sometimes called rebound hyperpigmentation. This is why aggressive laser settings or strong chemical peels that produce good results for sunspots can, in some patients with melasma, worsen the condition rather than improve it.

Effective melasma management is characterised by patience, gentleness, and a multi-modal approach. The aim is to progressively suppress overactive melanocytes and lift existing pigment while carefully avoiding further provocation of those cells. For those in Singapore, this also means contending with year-round high UV exposure — an environmental factor that requires consistent, diligent sun protection as an ongoing part of any management plan.

Prescription and Professional-Grade Topicals for Melasma

The following agents are among those that may be used in melasma management under medical supervision. Individual suitability varies depending on skin type, current medications, and clinical assessment.

Hydroquinone: A commonly prescribed topical that inhibits tyrosinase activity, reducing melanin synthesis. In Singapore, hydroquinone is classified as a prescription-only medicine and is not available over the counter. It is typically used for defined supervised periods.
Tretinoin and other retinoids: Accelerate cell turnover, facilitating the removal of pigmented cells and enhancing the penetration of other topical agents.
Azelaic acid: Selectively targets overactive melanocytes with a generally favourable tolerability profile.
Tranexamic acid: Acts on UV-induced melanin synthesis pathways. Topical forms may be incorporated into skincare under medical guidance. Oral tranexamic acid has been studied in clinical trials and shown benefit for melasma in certain patient populations; however, oral use constitutes off-label use in this context and should be under the direct supervision of a physician.
Cysteamine and kojic acid: Non-hydroquinone alternatives that may be considered as maintenance agents or in patients who do not tolerate hydroquinone.

In-Clinic Procedures for Melasma

When topical management alone is insufficient, certain gentle in-clinic procedures may be considered on an individual basis. The core principle is to minimise thermal and inflammatory stimulation of already-reactive melanocytes.

Superficial chemical peels: Gentle peels using glycolic, lactic, or mandelic acid can provide mild exfoliation to assist with pigment clearance over a series of treatments. Deeper peels are generally not recommended for melasma-prone skin.
Microneedling: May enhance the transdermal delivery of topical agents such as tranexamic acid by creating temporary micro-channels in the skin.
Low-energy laser protocols: Certain devices — such as low-fluence Q-switched Nd:YAG lasers or non-ablative fractional lasers (e.g. technologies such as Clear + Brilliant) — may be considered at conservative settings to assist with pigment reduction. These procedures require significant clinical expertise; inappropriate settings carry a meaningful risk of worsening the condition. A careful assessment by an experienced doctor is essential before proceeding.

Note: The suitability of any in-clinic procedure for melasma depends on the individual's skin type, pigment depth and distribution, and overall skin condition. A thorough clinical assessment by a qualified physician is required before any procedure is initiated.

Prevention: Protecting Your Skin for the Long Term

For both melasma and other forms of hyperpigmentation, prevention is one of the most reliably effective components of long-term skin management. Consistently addressing known triggers reduces the risk of new discolouration and helps maintain the improvement achieved through treatment.

Sun Protection

UV radiation is the primary environmental driver of virtually all types of hyperpigmentation. In Singapore, where UV intensity is elevated throughout the year, sun protection is a daily requirement — not a seasonal one.

Broad-spectrum sunscreen SPF 30 or higher: Apply every morning, regardless of weather or planned time outdoors. Mineral-based formulations containing zinc oxide or titanium dioxide physically block UV radiation and are often well tolerated by sensitive and melasma-prone skin.
Regular reapplication: Reapply at minimum every two hours during outdoor exposure, and after swimming or perspiration.
Physical sun protection: Wide-brimmed hats, UV-protective sunglasses, and seeking shade during peak UV hours (approximately 10:00 to 16:00) supplement sunscreen protection effectively.

Gentle Skincare Practices

Skin inflammation is a direct precursor to PIH and can also aggravate melasma. Maintaining practices that minimise unnecessary irritation helps protect against both.

Avoid picking or squeezing blemishes: Mechanical trauma significantly increases the risk of PIH, particularly in individuals with darker skin tones (Fitzpatrick IV to VI).
Introduce active ingredients gradually: Retinoids, AHAs, and other potent topical agents should be incorporated into a skincare routine slowly, to allow the skin barrier to adapt without becoming irritated.
Monitor your skin's response: Persistent redness, stinging, or dryness in response to a product may indicate that the skin barrier is being compromised. Discontinuing the offending product and allowing recovery is advisable.

Managing Melasma-Specific Triggers

Given the hormonal sensitivity and potential heat sensitivity associated with melasma, some additional preventive considerations apply.

Heat avoidance: Some patients with melasma report that exposure to significant heat — such as in saunas, steam rooms, or during intense exercise — is associated with worsening of their pigmentation. While the evidence base for this observation is still developing, reducing unnecessary heat exposure may be a reasonable consideration for individuals who notice this pattern.
Hormonal contraception: If you suspect that oral contraceptives or hormone replacement therapy may be contributing to your melasma, this is an important topic to discuss with your doctor. Changes to hormonal medication are sometimes part of an overall melasma management strategy.

Frequently Asked Questions

Can melasma go away on its own?

Melasma that develops during pregnancy (chloasma) sometimes fades after delivery as hormone levels return to baseline. However, melasma that arises independently of pregnancy tends to be more persistent and typically requires active management to maintain improvement. Even following successful treatment, melasma can recur with further UV exposure or hormonal changes — which is why ongoing sun protection and maintenance care are important components of long-term management.

How can I tell at home whether I have melasma or just dark spots?

The most useful self-assessment clue is symmetry. If the darkened patches appear on both sides of your face in a near-identical pattern — for example, matching patches on both cheeks, or a band across the forehead and upper lip — this is more consistent with melasma than with PIH or sunspots. That said, conditions can overlap in appearance, and a clinical assessment is necessary for a reliable diagnosis before any treatment is commenced.

Does sunscreen really help with melasma in Singapore's climate?

Yes. Consistent and adequate sun protection is a cornerstone of both melasma treatment and prevention. Singapore's year-round high UV intensity and elevated ambient temperatures make diligent sun protection especially important. A broad-spectrum SPF 30 or higher sunscreen, applied daily and reapplied during outdoor exposure, is a fundamental part of any melasma management plan. Mineral-based formulations are generally well tolerated by sensitive and melasma-prone skin.

Can laser treatment make melasma worse?

In some cases, yes. Melasma-affected skin contains melanocytes that are already in a sensitised, reactive state. Certain laser treatments — particularly those that generate significant heat — can trigger further melanin production if not carefully selected and applied. This is why the choice of device, treatment parameters, and practitioner experience is particularly important when treating melasma. Procedures that produce good results for sunspots or PIH may not be appropriate for melasma and, without careful clinical consideration, could worsen the condition. If you are considering laser treatment for melasma, consultation with an experienced doctor is essential.

What is a Wood's lamp examination and why does it matter?

A Wood's lamp is a handheld device that emits UV light and is used in a darkened room to illuminate the skin. It allows a clinician to assess the depth of pigmentation: superficial (epidermal) pigment appears enhanced under the lamp, while deeper (dermal) pigment does not. This distinction is clinically relevant because deeper pigment is generally more difficult to treat and may not respond as readily to topical agents. Knowing the depth of your pigmentation helps guide a more targeted and appropriate treatment plan.

How long does treatment for melasma or hyperpigmentation take?

There is no universal timeline. The rate and degree of improvement depend on the type and depth of pigmentation, individual skin characteristics, adherence to the treatment plan, and consistency of sun protection. In general, topical treatments may take several weeks to months to produce visible improvement. Melasma, in particular, tends to respond more gradually and requires consistent long-term management. Your doctor will be able to provide a more individualised expectation following clinical assessment.

Conclusion

The distinction between melasma and other forms of hyperpigmentation is not merely academic — it has direct and meaningful implications for treatment. All melasma is a form of hyperpigmentation, but melasma's combination of hormonal sensitivity, facial symmetry, and tendency to recur makes it a distinct and more complex entity than sunspots or PIH. General hyperpigmentation types often respond well to UV protection, brightening topicals, and light-based treatments. Melasma, by contrast, requires a more cautious and individualised approach that aims to suppress rather than provoke its underlying melanocyte reactivity.

Consistent broad-spectrum sun protection is a cornerstone of preventive care for all types of skin discolouration. If you are uncertain about the nature of your skin concern or are considering treatment, a consultation with a qualified doctor is the most appropriate first step — toward an accurate diagnosis and a personalised, safe management plan.

Note: This article is for educational purposes only and does not constitute medical advice. Individual treatment plans should be developed in consultation with qualified healthcare professionals. Treatment outcomes vary from person to person, and no guarantee of results is intended or implied. All professional treatments mentioned should be performed by licensed medical practitioners in Singapore, using HSA-approved or otherwise MOH-approved products, devices, and techniques, as applicable.

Please see below for treatment details.